Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 16/20 | 0.72 |
| ▸ | EGFR | P00533 | 11/20 | 0.72 |
| ▸ | ABL1 | P00519 | 8/20 | 0.72 |
| ▸ | ABL2 | P42684 | 8/20 | 0.72 |
| ▸ | CDK1 | P06493 | 4/20 | 0.72 |
| ▸ | CSK | P41240 | 2/20 | 0.72 |
| ▸ | KDR | P35968 | 5/20 | 0.60 |
| ▸ | LYN | P07948 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 2/20 | 0.46 |
| ▸ | PDE11A | Q9HCR9 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7845893 | 0.91 | SRC (0.73) | SRCEGFRABL1ABL2CDK1 | |
| SCHEMBL7841930 | 0.84 | SRC (1.00) | SRCEGFRABL1ABL2CDK1 | |
| SCHEMBL7833894 | 0.84 | SRC (0.84) | SRCEGFRABL1ABL2CDK1 | |
| SCHEMBL7844827 | 0.83 | SRC (0.59) | SRCEGFRABL1ABL2CDK1 | |
| SCHEMBL7845036 | 0.82 | SRC (0.88) | SRCEGFRABL1ABL2CDK1 | |
| SCHEMBL7847860 | 0.82 | SRC (0.81) | SRCEGFRABL1ABL2CDK1 | |
| SCHEMBL7843548 | 0.80 | SRC (0.72) | SRCEGFRABL1ABL2CDK1 | |
| SCHEMBL7847029 | 0.78 | SRC (0.54) | SRCEGFRABL1ABL2CDK1 | |
| SCHEMBL7846068 | 0.78 | SRC (0.70) | SRCEGFRABL1ABL2CDK1 | |
| SCHEMBL7845881 | 0.78 | SRC (0.58) | SRCEGFRABL1ABL2CDK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0783505-B1 | PYRROLO[2,3-d]PYRIMIDINES AND THEIR USE | NOVARTIS AG (CH) | 2001-03-07 | — | — | EP | disclosed |